ZNTL- Zentalis Pharmaceuticals, Inc.

Name: Zentalis Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Zentalis Pharmaceuticals, Inc. (ZNTL) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 36 sells. ZNTL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Walters Group	13.51M	$49.58M	-
10%	Matrix Capital Management Company, LP	6.46M	$23.71M	-
Other	Vultaggio Vincent	146.5K	$537.7K	-
Other	Bucher James B	100.0K	$367.0K	-
CEO	Eastland Julia Marie	79.1K	$290.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 11

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 7, 2021	Bunker Kevin D.78	Chief Operating Officer	Sell	24,812	$46.94	$1,164,675.07	-0.3%	+42.9%	-35.9%
Jul 2, 2021	Gallagher Cam81	Director	Sell	10,000	$49.58	$495,826.53	-0.7%	+33.9%	-41.7%
Jul 1, 2021	Bunker Kevin D.78	Chief Operating Officer	Sell	8,420	$51.23	$431,366.83	-7.1%	+19.3%	-43.7%
Jul 1, 2021	Epperly Melissa B,72	Chief Financial Officer	Sell	3,083	$51.27	$158,054.33	-0.3%	+19.3%	-43.7%
Jul 1, 2021	Sun Anthony Y81	President &CEO	Sell	26,794	$51.21	$1,372,234.86	-0.5%	+19.3%	-43.7%
Jun 1, 2021	Bunker Kevin D.78	Chief Operating Officer	Sell	8,420	$54.09	$455,441.75	-11.0%	+22.1%	-55.8%
Jun 1, 2021	Epperly Melissa B,72	Chief Financial Officer	Sell	3,083	$54.05	$166,640.95	-0.6%	+22.1%	-55.8%
Jun 1, 2021	Sun Anthony Y81	President &CEO	Sell	26,794	$54.03	$1,447,679.14	-0.9%	+22.1%	-55.8%
Jun 1, 2021	Gallagher Cam81	Director	Sell	10,000	$54.06	$540,551.32	-1.0%	+22.1%	-55.8%
May 3, 2021	Gallagher Cam81	Director	Sell	10,000	$59.25	$592,504.24	-0.5%	-16.5%	-55.8%

← PrevPage 11Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC